peka glp 1 The glucagon-like peptide (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action GLP-1 activates PKA and Epac2
Pay in 4 interest-free payments of $5.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30






















